Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 583

1.

Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.

Alexander HR, Fraker DL, Norton JA, Bartlett DL, Tio L, Benjamin SB, Doppman JL, Goebel SU, Serrano J, Gibril F, Jensen RT.

Ann Surg. 1998 Aug;228(2):228-38.

2.
3.

Somatostatin receptor scintigraphy in gastrinomas.

Jensen RT, Gibril F.

Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S179-85. Review.

PMID:
10604126
4.

A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas.

Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbeyn V, Benya RV, Shawker TH, Doppman JL, Jensen RT.

Ann Surg. 1993 Aug;218(2):138-44.

5.

Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT.

Ann Surg. 2004 May;239(5):617-25; discussion 626.

6.

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.

Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT.

Ann Intern Med. 1996 Jul 1;125(1):26-34.

PMID:
8644985
7.

Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.

Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, Ruszniewski P, Le Guludec D, Mignon M.

Gastroenterology. 1996 Oct;111(4):845-54.

PMID:
8831579
8.
9.

Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.

Termanini B, Gibril F, Reynolds JC, Doppman JL, Chen CC, Stewart CA, Sutliff VE, Jensen RT.

Gastroenterology. 1997 Feb;112(2):335-47.

PMID:
9024287
10.

Localization, malignant potential, and surgical management of gastrinomas.

Kisker O, Bastian D, Bartsch D, Nies C, Rothmund M.

World J Surg. 1998 Jul;22(7):651-7; discussion 657-8.

PMID:
9606277
11.

Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.

Gibril F, Reynolds JC, Chen CC, Yu F, Goebel SU, Serrano J, Doppman JL, Jensen RT.

J Nucl Med. 1999 Apr;40(4):539-53.

12.

Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.

Norton JA, Doppman JL, Collen MJ, Harmon JW, Maton PN, Gardner JD, Jensen RT.

Ann Surg. 1986 Oct;204(4):468-79.

13.

Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.

Frucht H, Howard JM, Stark HA, McCarthy DM, Maton PN, Gardner JD, Jensen RT.

Am J Med. 1989 Nov;87(5):528-36.

PMID:
2573280
14.

Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.

Norton JA, Fraker DL, Alexander HR, Jensen RT.

Ann Surg. 2012 Sep;256(3):509-17. doi: 10.1097/SLA.0b013e318265f08d.

15.

Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.

Nikou GC, Toubanakis C, Nikolaou P, Giannatou E, Marinou K, Safioleas M, Karamanolis D.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1668-76.

PMID:
16334754
16.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
17.

Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome.

Thompson NW, Pasieka J, Fukuuchi A.

World J Surg. 1993 Jul-Aug;17(4):455-62.

PMID:
8103249
18.
19.

Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.

Mortellaro VE, Hochwald SN, McGuigan JE, Copeland EM, Vogel SB, Grobmyer SR.

Am Surg. 2009 Aug;75(8):730-3.

PMID:
19725300
20.

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

Fishbeyn VA, Norton JA, Benya RV, Pisegna JR, Venzon DJ, Metz DC, Jensen RT.

Ann Intern Med. 1993 Aug 1;119(3):199-206.

PMID:
8323088
Items per page

Supplemental Content

Write to the Help Desk